OXFORD Immune Algorithmics — 2232987
Application number
2232987
Registration number
TMA1416888
International Registration Number
1707077
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2022-03-21
International Registration
2022-03-21
Registered
2026-06-05
Registration Expiry Date
2032-03-21
Registered Owner
Oxford Immune Algorithmics Ltd
Davidson House,
The Forbury
Reading RG1 3EU
UNITED KINGDOM
Agent
OYEN WIGGS GREEN & MUTALA LLP
480-THE STATION, 601 WEST CORDOVA STREET
VANCOUVER
BRITISH COLUMBIA V6B1G1
Documents
Index headings
- OXFORD IMMUNE ALGORITHMICS
Vienna information (Code & Description)
- 1.15.23
- Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).
- 26.5.1
- One polygon
- 26.3.23
- Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.
- 1.15.9
- Luminous sources, rays, shafts of light
- 29.1.1
- Red, pink, orange
- 29.1.8
- Black
Colour claim
Colour is claimed as a feature of the trademark. The colour(s) red, black, dark red and light red is/are claimed as a feature of the trademark. The trademark consists of the word OXFORD in black, the word Immune in dark red, and the word Algorithmics in light red, all under a design consisting of a pentagon outlined in red with red lines extending from the pentagon outline at various points. The colour white represents background and/or transparent areas and is not claimed as a feature of the trademark.
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical antibody preparations for auto-immune diseases; biochemical preparations for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; biological reagents for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; blood components for gene therapy, cell therapy and immunotherapy; blood for medical purposes; chemical diagnostic reagents for medical use; chemical preparations for testing blood for medical purposes for the detection, prevention and treatment of autoimmune diseases and disorders; chemical reagents for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; chemical test reagents for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; chemicals for pharmaceutical use for the detection, prevention and treatment of autoimmune diseases and disorders; chemico-pharmaceutical preparations for the detection, prevention and treatment of autoimmune diseases and disorders; clinical diagnostic reagents for medical diagnostic use; clinical medical reagents for medical diagnostic use; diagnostic agents for medical diagnostic use; diagnostic agents for pharmaceutical diagnostic use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations and materials for medical laboratory use and for the detection, prevention and treatment of autoimmune diseases and disorders; diagnostic preparations for medical or veterinary purposes for medical laboratory use and the detection of blood ketones and blood lactate; diagnostic preparations for medical diagnostic purposes; diagnostic reagents for medical use; diagnostic reagents for medicinal use; diagnostic substances for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; diagnostic testing materials for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; genetic identity tests comprised of reagents for medical purposes; hemoglobin; human immune globulin for the detection, prevention and treatment of autoimmune diseases and disorders; immunoassay reagents for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; in vitro diagnostic preparations for medical use; indicators for medical diagnosis for the detection, prevention and treatment of autoimmune diseases and disorders; living cells for medical use for the detection, prevention and treatment of autoimmune diseases and disorders; living cells for veterinary use for the detection, prevention and treatment of autoimmune diseases and disorders; medicine for the detection, prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for regulating the immune system; pharmaceutical chemico-preparations for suppressing tumors; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune disorders; chemico-pharmaceutical preparations for the prevention of diseases caused by bacteria; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; chemico-pharmaceutical preparations for the prevention of diseases of the endocrine system, namely, neuromuscular diseases, namely primary periodic paralysis and glucagonoma; chemico-pharmaceutical preparations for the prevention of diseases of the genitourinary system, namely, urological diseases, sexually transmitted diseases, inflammatory pelvic diseases; chemico-pharmaceutical preparations for the prevention of diseases of the immune system, namely, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, celiac disease, lupus; chemico-pharmaceutical preparations for the prevention of diseases of the metabolic system, namely, diabetes, gout, arthritis, and anemia; chemico-pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; chemico-pharmaceutical preparations for the prevention of diseases of the nervous system, namely, diseases of the central nervous system and diseases of the peripheral nervous system; pharmaceutical preparations for the prevention of diseases of the respiratory system; chemico-pharmaceutical preparations for the prevention of disorders caused by bacteria; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; chemico-pharmaceutical preparations for the prevention of disorders of the endocrine system, namely, growth and thyroid disorders and adrenal insufficiency; chemico-pharmaceutical preparations for the prevention of disorders of the genitourinary system, namely, urological disorders, kidney stones, ovarian cysts, prostatitis; chemico-pharmaceutical preparations for the prevention of disorders of the immune system, namely, autoimmune disorders; chemico-pharmaceutical preparations for the prevention of disorders of the metabolic system, namely, diabetes, anorexia, hypothyroidism and obesity; chemico-pharmaceutical preparations for the prevention of disorders of the musculo-skeletal system; chemico-pharmaceutical preparations for the prevention of disorders of the nervous system, namely, for treatment of peripheral nervous system disorders, central nervous system movement disorders and ocular motility disorders; pharmaceutical preparations for the prevention of disorders of the respiratory system; chemico-pharmaceutical preparations for the prevention of inflammatory diseases, namely, inflammatory connective tissue diseases; pharmaceutical preparations for the prevention of inflammatory disorders, namely, inflammatory connective tissue disorders; chemico-pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; chemico-pharmaceutical preparations for the treatment of bone diseases; chemico-pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; chemico-pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; chemico-pharmaceutical preparations for the treatment of diseases of the endocrine system, namely, neuromuscular diseases, namely primary periodic paralysis, glucagonoma; chemico-pharmaceutical preparations for the treatment of diseases of the metabolic system, namely, diabetes, arthritis, high blood pressure, metabolic syndrome; chemico-pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; chemico-pharmaceutical preparations for the treatment of disorders caused by bacteria; chemico-pharmaceutical preparations for the treatment of disorders of the endocrine system, namely, growth and thyroid disorders, adrenal insufficiency; chemico-pharmaceutical preparations for the treatment of disorders of the genitourinary system, namely, urological disorders, kidney stones, ovarian cysts, prostatitis; chemico-pharmaceutical preparations for the treatment of disorders of the metabolic system, namely, hemochromatosis, anemia, insulin resistance; chemico-pharmaceutical preparations for the treatment of hormonal disorders; chemico-pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, celiac disease, lupus, psoriasis, asthma, eczema, immunologic deficiency syndromes; chemico-pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; chemico-pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; chemico-pharmaceutical preparations for the treatment of inflammatory disorders, namely, inflammatory muscle disorders, asthma; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of parkinson's disease; chemico-pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); chemico-pharmaceutical preparations for treating chemical imbalances, namely, for treatment of neurological and neuro-psychiatric diseases, disorders and conditions, namely, anxiety disorders, bipolar disorders, psychoses, schizophrenia; chemico-pharmaceutical preparations for treating metabolic disorders, namely, hemochromatosis, anemia, insulin resistance; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for use in chemotherapy; chemico-pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; chemico-pharmaceutical preparations for veterinary use for treatment of infectious diseases in poultry; chemico-pharmaceutical preparations as drug delivery agents in the form of dissolvable film strips that facilitate the delivery of pharmaceutical preparations; chemico-pharmaceutical products for the treatment of bone diseases; chemico-pharmaceutical products for the treatment of cancer; chemico-pharmaceutical products for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); chemico-pharmaceutical products for treating respiratory diseases, namely, inhalant anaesthetics; chemico-pharmaceutical preparations for the treatment of gluten intolerance and celiac disease; reagents and media for medical and veterinary diagnostic purposes for the detection, prevention and treatment of autoimmune diseases and disorders; chemical reagents for medical or veterinary purposes for the detection, prevention and treatment of autoimmune diseases and disorders; medical diagnostic reagents for analytical purposes for the detection, prevention and treatment of autoimmune diseases and disorders; veterinary diagnostic reagents for analytical purposes for the detection, prevention and treatment of autoimmune diseases and disorders; diagnostic reagents for medical use in in-vitro laboratory diagnosis; diagnostic reagents for veterinary purposes in in-vitro laboratory diagnosis; reagents for medical use; veterinary diagnostic reagents for microbiological analysis; medical diagnostic reagents for use in analysis for the detection, prevention and treatment of autoimmune diseases and disorders; veterinary diagnostic reagents for use in analysis for the detection, prevention and treatment of autoimmune diseases and disorders; reagents for use in medical diagnostic tests for the detection, prevention and treatment of autoimmune diseases and disorders; reagents for use in veterinary diagnostic tests for the detection, prevention and treatment of autoimmune diseases and disorders; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; reagents for medical use with analyzers for the detection, prevention and treatment of autoimmune diseases and disorders; diagnostic reagents for veterinary purposes for use with analyzers for the detection, prevention and treatment of autoimmune diseases and disorders; chemical preparations for testing blood for medical diagnostic purposes; blood for medical purposes; reagents for medical use in blood grouping for the detection, prevention and treatment of autoimmune diseases and disorders; chemical preparations for medical purposes for use in dna analysis for the detection, prevention and treatment of autoimmune diseases and disorders; drug delivery agents for the detection, prevention and treatment of autoimmune diseases and disorders; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations for the detection, prevention and treatment of autoimmune diseases and disorders; drug detoxifying agents for the detection, prevention and treatment of autoimmune diseases and disorders; drugs for medical purposes for the detection, prevention and treatment of autoimmune diseases and disorders; anti-cancer drugs; antiepileptic drugs; antimigraine drugs; antineoplastic drugs; antipyretic drugs with sedative effect; antiseizure drugs; antituberculous drugs; antitumor drugs; antiviral drugs for treating HIV; antiviral drugs for treating influenza; autonomic drugs for the detection, prevention and treatment of autoimmune diseases and disorders; autonomic drugs for medical purposes for the detection, prevention and treatment of autoimmune diseases and disorders; cardiovascular drugs for use in treating hypertension; cardiovascular drugs used in angina pectoris; cardiovascular drugs used in myocardial infarction; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in treating congestive heart failure (CHF); cardiovascular drugs used in treating shocks; crude drugs for the detection, prevention and treatment of autoimmune diseases and disorders; cytostatic drugs for medical purposes for the detection, prevention and treatment of autoimmune diseases and disorders; hypoglycemic drugs for treating diabetes; non-steroidal anti-inflammatory drugs; organotherapeutic drugs for the detection, prevention and treatment of autoimmune diseases and disorders; pharmaceutical drugs for the detection, prevention and treatment of autoimmune diseases and disorders; DNA synthesis inhibitors for the detection, prevention and treatment of autoimmune diseases and disorders; chemical preparations for medical purposes for use in dna analysis for the detection, prevention and treatment of autoimmune diseases and disorders.
- 9
- (2) Computer software, recorded, for monitoring the human and animal body systems to detect, prevent, treat and test for diseases; downloadable computer software and computer application software for mobile devices for use in monitoring the human and animal body systems to detect, prevent, treat and test for diseases; downloadable computer software applications for monitoring the human and animal body systems to detect, prevent, treat and test for diseases; downloadable software applications for mobile devices for monitoring the human and animal body systems to detect, prevent, treat and test for diseases; software applications for use with mobile devices to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication; downloadable software converters of natural language into machine executable commands for use in monitoring the human and animal body systems to detect, prevent, treat and test for diseases; downloadable software development programmes to facilitate monitoring of the human and animal body systems to detect, prevent, treat and test for diseases; downloadable software development tools for use in monitoring the human and animal body systems to detect, prevent, treat and test for diseases; downloadable software for computers for monitoring the human and animal body systems to detect, prevent, treat and test for diseases; software for online messaging; software for operating and managing integrated circuit components; software for optical character recognition; software for processing digital images; software for processing images, graphics and text; software for processing images, graphics, audio, video and text; downloadable application software to facilitate patient access to blood and cell testing results and analysis; downloadable application software for cloud computing services to facilitate patient access to blood and cell testing results and analysis; downloadable artificial intelligence software for analysis of blood and cells in humans; downloadable artificial intelligence software provided in the field of healthcare for testing and analysis of blood and cells in humans; downloadable authentication software to provide patient access to blood and cell testing results and analysis; bioinformatics software; biometric software; computer interface software; computer programming software for operating system programs to control and manage access to patient medical information; medical research laboratory blood gas, blood type and body fluid analyzers for measuring, testing and analyzing blood and other bodily fluids, namely bile, mucus, pus, saliva, urine; digital optical transmission apparatus namely optical transmitters for testing analysis of blood and cells in humans and detecting, preventing, and treating human disease; optical barcode recognition [OBR] software; optical character recognition [OCR] software; computer accelerator board; computer apparatus namely, keyboards, screens, computer mouses, hard drives; computer application software for streaming audio-visual media content via the internet; computer application software for controlling networked devices using the internet of things [IOT] to collect, process and transmit patient healthcare data and healthcare information; computer application software for use with wearable electronic devices to track and monitor users' medical information, symptoms and blood glucose levels for medical purposes; DNA microarray, namely microarray slides; DNA chips; humanoid robots with artificial intelligence; laboratory robots; telepresence robots; artificial intelligence and machine learning software in the field of big data for business data analytics and user behavior analytic; artificial intelligence software in the field of big data for business data analytics and user behavior analytic; artificial intelligence software for analysis; artificial intelligence software for healthcare in the field of big data for business data analytics and user behavior analytic; humanoid robots with artificial intelligence; quantum dot light-emitting diodes [QLED]; crystalline semi-conductor materials namely quantum dots; microscope condensers; microscope illuminating devices; microscope lamps; microscope objectives; microscope slides; containers for microscope slides; microscope video processors; microscopes; microscopes for medical use; biological microscopes; lens-barrels and body-tubes for microscopes; electron microscopes; fluorescence microscopes; LED microscopes; lenses for microscopes; operating microscope stands; polarizing microscopes; prisms for microscopes; reflectors for microscopes; scanning electron microscopes; scanning probe microscopes; toolmakers microscopes; transmission electron microscopes; zoom microscopes; none of the above goods relating to the education sector.
- 10
- (3) Apparatus for blood monitoring, namely blood oxygen monitors, blood glucose meters; apparatus for blood tests for medical use for testing analysis of blood and cells in humans and detecting, preventing, and treating human diseases, namely blood glucose test strips and blood ketone monitors; apparatus for determining blood flow, namely hand held ultrasound transducers; apparatus for taking blood; apparatus for taking blood samples; autologous blood processing instruments, namely, syringes, needles and tourniquets; hypodermic needles for collecting blood; blood collection tubes for medical use; blood filters; apparatus for administering drugs by inhalation, namely inhalers with valved holding chamber used to improve the delivery of medication to the lungs; apparatus for drug administration, namely infusion pumps, inhalers with valved holding chamber used to improve the delivery of medication to the lungs, hypodermic needles, cardiovascular needles, hypodermic syringes, syringes for medical purposes, intravenous catheters, intravenous feeding bottles; implantable subcutaneous drug delivery devices; medical instruments for drug abuse testing for the detection of drugs; medical instruments for therapeutic drug monitoring for the detection of drugs; medical tubing for administering drugs; medical metering pumps for delivering drugs in measured quantities; diagnostic and testing apparatus for DNA and RNA exams for clinical medical purposes; diagnostic and testing apparatus for DNA and RNA testing for clinical medical purposes; none of the above goods relating to the education sector.
Services (Nice class & Statement)
- 35
- (1) Business consulting in the field of medicine; business consulting for enterprises in the field of medicine; business consulting services in the field of medicine; business management consulting; business management consulting services; business management consulting services in the field of information technology; business marketing consulting services; business organisation and management consulting; business organisation and management consulting services; business organization and management consulting; business organization consulting; business planning and business continuity consulting; business process management and consulting; business research consulting; marketing consulting; personnel management consulting; professional business consulting in the field of life sciences and healthcare; providing marketing consulting in the field of social media; tax preparation and income tax consulting services; consulting and information concerning accounting; consulting in sales techniques and sales programmes; consulting services in business organization and management; consulting services in the field of internet marketing; consulting services relating to business marketing; consulting services relating to publicity; providing administrative assistance to pharmacies for managing drug inventories; none of the above services relating to the education sector.
- 41
- (2) Courses for the development of consulting skills in the medical field; arrangement of training courses in teaching institutes in the medical field; arranging and conducting of day school courses for adults in the medical field; arranging and conducting of educational courses in the medical field; arranging and conducting of training courses in the field of medical science; arranging for students to participate in educational courses in the medical field; arranging of training courses in the medical field; arranging professional workshop and training courses in the medical field; arranging technical instruction courses in the medical field; conducted basic literacy courses (provision of -); conducting courses, seminars and workshops in the medical field; conducting instructional courses in the medical field; conducting of educational courses in the field of medicine; conducting of educational courses in business management; conducting of educational courses in the field of engineering; conducting of educational courses in the field of science; conducting of educational courses relating to business management; conducting training courses relating to diet online; conducting training courses relating to nutrition online; consultancy services relating to the development of training courses in the medical field; correspondence courses relating to cookery; correspondence courses relating to gardening; correspondence courses relating to personal investment; development of educational courses and examinations in the field of medicine; distance learning courses in the field of medicine; education services in the nature of courses at the university level; instruction courses related to slimming; instruction courses relating to health conditions; instruction courses relating to physical fitness; language courses; organisation of language courses; organisation of training courses in the medical field; personal development courses; postgraduate training courses; postgraduate training courses relating to engineering technology; preparation of educational courses and examinations in the medical field; providing continuing dental education courses; providing continuing legal education courses; providing continuing medical education courses; providing continuing nursing education courses; providing courses in the field of water management; providing courses of instruction at college level; providing courses of instruction at high school level; providing courses of instruction at post-graduate level; providing training courses on business management; provision of courses of instruction in languages; provision of courses of instruction in self awareness; provision of courses of instruction in the removal of unwanted hair; provision of courses of instruction relating to caravanning; provision of courses of instruction relating to personal time management; provision of education courses in the medical field; provision of educational courses relating to diet; provision of language schools and language courses; provision of medical instruction courses; provision of training courses for young people in preparation for careers; provision of training courses for young people in preparation for employment; provision of training courses for young people in preparation for vocations; provision of training courses in personal development; residential education courses relating to abseiling; residential education courses relating to archery; residential education courses relating to canoeing; residential education courses relating to hill walking; review courses for state examinations; school courses relating to examination preparation; school courses relating to study assistance; self-awareness courses [instruction]; specialisation courses for oncological doctors; training courses in the medical field; training courses in engine design; training courses in jointing of optical fibres; training courses in strategic planning relating to advertising, promotion, marketing and business; training courses relating to computer hardware; training courses relating to data base designs; vocational training courses (provision of -); courses (training -) relating to accountancy; training courses relating to medicine; courses (training -) relating to philosophical subjects; courses (training -) relating to religious subjects; courses (training -) relating to research and development in the medical field; education services relating to the abuse of drugs; vocational education relating to avoidance of drug related problems.
- 42
- (3) Software as a service featuring non-downloadable software for monitoring the human and animal body systems to detect, prevent, treat and test for diseases; software as a service [saas] featuring computer software platforms for artificial intelligence that facilitate use of artificial intelligence in the field of medicine; software as a service [saas] featuring software for deep learning; software as a service [saas] featuring software for deep neural networks; software as a service [saas] featuring software for machine learning; software as a service [saas] services featuring software for machine learning, deep learning and deep neural networks; software consultancy services; advisory services in the field of product development and quality improvement of software; advisory services relating to computer software design; advisory services relating to man-machine interfaces for computer software; advisory services relating to the rental of computers or computer software; advisory services relating to the use of computer software; software engineering; software engineering services; software installation; software maintenance services; computer software consultancy; computer software consultancy services; computer software consultation; computer software consulting; computer software development; computer software engineering; blood analysis services; blood analysis services for scientific research purposes; analysis of human serum for medical research; computer software consulting; computer software consulting services; control technology consulting services; professional consulting services and advice about agricultural chemistry; software consulting services; technical consulting in the field of environmental engineering; consulting in the field of cloud computing networks and applications; consulting services in the field of cloud computing; consulting services in the field of software as a service [saas]; consulting services relating to computer software; scientific research in the field of pharmacy; drug discovery services; pharmaceutical drug development services; services for assessing the efficiency of veterinary drugs; advice and consultancy in relation to computer networking applications; advice relating to the design of computer hardware; computer system analysis services; analytical services relating to computer programmes; DNA screening for scientific research purposes; engineering services relating to robotics; platforms for artificial intelligence as software as a service [saas] in the field of medicine; providing artificial intelligence computer programs on data networks in the field of medicine; software as a service [saas] featuring computer software platforms for artificial intelligence in the field of medicine; none of the above services relating to the education sector.
- 44
- (4) Services for the testing of blood; medical analysis for the diagnosis and treatment of persons to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; medical analysis services for the analysis of blood samples taken from patients, for diagnostic and treatment purposes provided by laboratories, and relating to patient treatment; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of persons provided by a medical laboratory; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; pharmacy advice; pharmacy advisory services; pharmacy services; drug screening for medical purposes; drug testing for substance abuse; drug testing of participants in sports for the use of illegal or prohibited performance enhancing substances; drug use screening services; drug, alcohol and dna screening for medical purposes; pre-employment drug screening; rehabilitation of drug addicted patients; dna screening for medical purposes; drug, alcohol and dna screening for medical purposes; medical and health testing and screening services relating to dna testing and dna screening, genetics screening and genetic testing; rna or dna analysis for cancer diagnosis and prognosis; none of the above services relating to the education sector.
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| International Registration | 2022-03-21 | 2032-03-21 | |
| Filed | 2022-03-21 | Registration | |
| Formalized | 2023-01-11 | ||
| Created | 2023-01-11 | ||
| Designation Notification - Madrid Protocol | 2023-01-12 | 2024-07-12 | |
| Notification of Possible Opposition Sent | 2023-11-13 | ||
| Search Recorded | 2024-04-24 | ||
| Examiner's First Report | 2024-04-24 | 2024-10-24 | |
| Total Provisional Refusal | 2024-04-24 | 2024-10-24 | |
| Agent Changed | 2025-05-09 | From: To: 5793 / Voir Preuve au dossier/See evidence on File No. 2232987 | |
| Correspondence Created | 2025-05-15 | 2025-11-15 | |
| Correspondence Created | 2025-08-06 | 2026-02-06 | |
| Approved | 2025-12-31 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-12-31 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2026-03-18 | Vol.73 Issue 3725 | |
| Opposition Start Date Notice Sent | 2026-03-18 | Requested on 2026/03/18 00:30:04 in program jr500m1 | |
| Registration Pending | 2026-06-05 | ||
| Registered | 2026-06-05 | ||
| Statement of Grant of Protection Sent (following a Provisional Refusal) | 2026-06-05 |